Cite Score
0.6
SCImago Journal Rank
0.159
Source Normalized Impact per Paper
0.141
Acta Haematologica Polonica
From 1 January 2021, manuscript to Acta Haematologica Polonica should be submitted at: journals.viamedica.pl/acta_haematologica_polonica.
Acta Haematologica Polonica provides interdisciplinary assistance in the fields of oncology, experimental haematology, laboratory haematology, cytometry, coagulation studies, transfusion medicine, and transplantology. The journal publishes original experimental papers, case studies and review articles. We also publish recommendations and guidelines of specialist teams of Polish and international haematologists and transfusion specialists.
Papers published in Acta Haematologica Polonica cover specifically such topics as physiology and pathology in haematology and transfusion, focusing on the following areas:
- leukocytes
- erythrocytes
- blood platelets
- immunological system
- mechanisms of haemostasis
- clinical aspects of hyperplastic haematological diseases
- new advances in therapy
- and transplantology.
Authors of papers published in Acta Haematologica Polonica are researchers from leading clinical and academic centres. Target readership of the journal includes both medical doctors practicing medicine at research level as well as those working in clinics.
Acta Haematologica Polonica is the official journal of the Polish Society of Haematology and Blood Transfusion, and the Institute of Haematology and Transfusion Medicine, associated with Polish haematology and (blood) transfusion since 1970.
Articles submitted to the journal are first classified by Section Editor and then evaluated using the double blind peer review method. Articles in both Polish and English are accepted for publication. In addition to regular issues, the Editorial office prepares special issues associated with key conferences in the field.
In case of any technical problems, please contact the Journal Office at: acta.haematologica@gmail.com
Archiving
Sciendo archives the contents of this journal in Portico - digital long-term preservation service of scholarly books, journals and collections.
Plagiarism Policy
The editorial board is participating in a growing community of Similarity Check System's users in order to ensure that the content published is original and trustworthy. Similarity Check is a medium that allows for comprehensive manuscripts screening, aimed to eliminate plagiarism and provide a high standard and quality peer-review process.
Acta Haematologica Polonica ist in den folgenden Services indiziert:
- Baidu Scholar
- CNKI Scholar (China National Knowledge Infrastructure)
- CNPIEC - cnpLINKer
- EBSCO Discovery Service
- Google Scholar
- J-Gate
- KESLI-NDSL (Korean National Discovery for Science Leaders)
- MyScienceWork
- Naver Academic
- Naviga (Softweco)
- Primo Central (ExLibris)
- QOAM (Quality Open Access Market)
- ReadCube
- SCOPUS
- Semantic Scholar
- Summon (ProQuest)
- TDNet
- Web of Science - Biological Abstracts
- Web of Science - BIOSIS Previews
- WorldCat (OCLC)
- External Web Links:
Band 51 (2020): Heft 4 (Dec 2020)
Open Access Statement
The journal is an Open Access journal that allows a free unlimited access to all its contents without any restrictions upon publication to all users.
Editor-in-Chief
Prof. dr hab. n. med. Jan Styczyński, Collegium Medicum, Nicolaus Copernicus University, Poland
Prof. dr hab. n. med. Jan Styczyński, Collegium Medicum, Nicolaus Copernicus University, Poland
Associate Editor-in-Chief
Prof. dr hab. n. med. Ewa Lech-Marańda
Secretary
Dr n. med. Agnieszka Karczmarczyk
Associate Editors
Prof. dr hab. Tomasz Szczepański – pediatric hematooncology, molecular biology
Prof. dr hab. Sebastian Giebel – transplantology
Prof. dr hab. Iwona Hus – lymphoproliferations
Prof. dr hab. Lidia Gil – acute leukemia, myeloproliferations
Prof. dr hab. Magdalena Łętowska – transfusion medicine
Dr hab. Joanna Rupa-Matysek – non-malignant hematology
Dr hab. Andrzej Mital – hemostasis
Dr n. med. Tomasz Stokłosa – molecular biology, leukemogenesis
Statistical Editor
Prof. dr hab. Andrzej Tukiendorf, Department of Public Health, Wrocław Medical University, Wrocaw, Poland
International Advisory Board
Prof. Jane Apperley, Department of Haemotology, Imperial College London, UK
Prof. Zwi N. Berneman, Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerpen, Belgium
Prof. Alain Berrebi, Israel Hematology Institute, Kaplan Medical Center, Tel Aviv University, Rehovot, Israel
Dr. Cedrik Britten, Translational Oncology at the University Medical Center of the Johannes Gutenberg-University Mainz, Germany
Prof. Lars Bullinger, Medical Department, Division of Hematology, Oncology and Tumor Immunology, Charité – University of Berlin, Germany
Prof. dr hab. n. med. Krzysztof Giannopoulos, Department of Experimental Hematooncology, Medical University of Lublin; Hematology Department, Lublin Oncology Center in Lublin
Prof. Jakub Gołąb, Department of Immunology, Medical University of Warsaw, Poland
Prof. Andrzej Hellmann, Department of Hematology and Transplantation, Medical University of Gdansk, Poland
Prof. Andrzej Jakubowiak, Department of Medicine, University of Chicago Medical Center, Chicago, USA
Prof. Wiesław Jędrzejczak, Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Poland
Prof. Przemysław Juszczyński, Department of Hematology, Institute of Hematology and Blood Transfusion Medicine, Medical University of Warsaw, Poland
Prof. Anna Korycka-Wołowiec, Department of Hematology, Medical University of Lodz, Poland
Prof. Sławomira Kyrcz-Krzemień, Dept. of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland
Prof. Krzysztof Lewandowski, Department of Haematology and Proliferative Diseases of Hematopoietic System, Medical University of Poznan, Poland
Prof. Per Ljungman, Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital, and Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
Prof. Maciej Machaczka, Department of Hematology, Karolinska University Hospital, Stockholm, Sweden
Prof. Grzegorz Mazur, Department and Clinic of Internal and Occupational Diseases and Hypertension, Medical University of Wroclaw, Poland
Prof. Jaroslav Michalek, Advanced Cell Immunotherapy Unit, Department of Pharmacology, Medical Faculty, Masaryk University, Brno, Czech Republic
Prof. Małgorzata Mikulska, Division of Infectious Diseases, Department of Health Sciences (DISSAL), University of Genoa; IRCCS Ospedale Policlinico San Martino, Genova, Italy
Prof. Ken Mills, Blood Cancer Research Group, Centre for Cancer Research and Cell Biology, Queens University Belfast, UK.
Dr hab. Beata Piątkowska-Jakubas, Department and Clinic of Haematology, Jagiellonian University Medical College, Krakow, Poland
Prof. Maria Podolak-Dawidziak, Department of Hematology, Blood Cancer and Bone Marrow Transplantation, Medical University of Wroclaw, Poland
Prof. Aaron Polliack, Dept.of Hematology, Hebrew University Hadassah Medical School, Jerusalem, Israel
Prof. Mariusz Ratajczak, Department of Medicine, Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky
Prof. Tadeusz Robak, Department of Hematology, Medical University of Lodz, Poland
Prof. Jacek Roliński, Department of Clinical Immunology, Medical University of Lublin, Poland
Prof. Michael Schmitt, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
Prof. Aleksander Skotnicki, Department and Clinic of Haematology, Jagiellonian University Medical College, Krakow, Poland
Prof. Viggo F.I. Van Tendeloo, Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Belgium
Prof. Jacek Wachowiak, Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Poznan, Poland
Prof. Jan Walewski, Maria Sklodowska-Curie Memorial Institute-Centre of Oncology, Warsaw, Poland
Prof. Krzysztof Warzocha, Hematology Unit, Regional Hospital in Kołobrzeg, Poland
Prof. Peter H. Wiernik, Cancer Research Foundation of New York, Chappaqua, USA
Prof. Dominik Wolf, Department of Hematology, Oncology and Rheumatology, Center of Integrated Oncology Cologne Bonn, University Hospital of Bonn, Germany
Prof. Dariusz Wołowiec, Department and Clinic of Haematology, Blood Neoplasm and Bone Marrow Transplantation, Medical University of Wroclaw, Poland
Prof. Thorsten Zenz, Molecular Therapy in Hematology and Oncology, National Center for Tumor Diseases Heidelberg and German Cancer Research Center, Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany
Editor's Address
Department of Pediatrics, Hematology and Oncology
Collegium Medicum, Nicolaus Copernicus University
University Hospital No. 1
ul. Skłodowskiej-Curie 9
85-094 Bydgoszcz
fax 52 585 4087
e-mail: acta.haematologica@gmail.com
Publisher
De Gruyter Poland
Bogumiła Zuga 32A Str.
01-811 Warsaw, Poland
T: +48 22 701 50 15
